INHIBITION OF EJACULATION DUE TO EPSILON AMINOCAPROIC ACID

被引：0
|
作者：
EVANS, BE [1 ]
ALEDORT, LM [1 ]
机构：
[1] CUNY,MT SINAI SCH MED,INT TRAINING CTR HEMOPHILIA,NEW YORK,NY 10029
来源：
NEW ENGLAND JOURNAL OF MEDICINE | 1978年 / 298卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：166 / 167
页数：2
相关论文
共 50 条
  • [31] The Effective Concentration of Epsilon-Aminocaproic Acid for Inhibition of Fibrinolysis in Neonatal Plasma in Vitro
    Yurka, Heather G.
    Wissler, Richard N.
    Zanghi, Christine N.
    Liu, Xiang
    Tu, Xin
    Eaton, Michael P.
    ANESTHESIA AND ANALGESIA, 2010, 111 (01): : 180 - 184
  • [32] EPSILON-AMINOCAPROIC ACID AND SUBARACHNOID HEMORRHAGE
    SHAW, MDM
    MILLER, JD
    LANCET, 1974, 2 (7884): : 847 - 848
  • [33] TREATMENT OF EXPERIMENTAL PANCREATITIS WITH EPSILON AMINOCAPROIC ACID
    ANDERSON, MC
    BERGAN, JJ
    JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1966, 196 (06): : 579 - &
  • [34] CRYSTAL STRUCTURE OF EPSILON-AMINOCAPROIC ACID
    BODOR, G
    BEDNOWIT.AL
    POST, B
    ACTA CRYSTALLOGRAPHICA, 1967, 23 : 482 - &
  • [35] INHIBITION BY EPSILON-AMINOCAPROIC ACID OF ACTIVATION OF FIRST COMPONENT OF COMPLEMENT-SYSTEM
    SOTER, NA
    AUSTEN, KF
    GIGLI, I
    JOURNAL OF IMMUNOLOGY, 1975, 114 (03): : 928 - 932
  • [36] THE MECHANISM OF HEPATOPROTECTION BY EPSILON AMINOCAPROIC ACID AND PUTRESCINE
    PUTNAM, CW
    BUCKLEY, AR
    WARNEKE, JA
    KARRER, FM
    RHENMAN, B
    STEINBRONN, K
    SURGERY, 1984, 96 (02) : 214 - 222
  • [37] EPSILON AMINOCAPROIC ACID - A FIBRINOLYTIC POTENTIATOR IN DOG
    GUEST, MM
    BOND, TP
    FEDERATION PROCEEDINGS, 1970, 29 (02) : A648 - +
  • [38] EPSILON-AMINOCAPROIC ACID FOR HEMATURIA IN HEMOPHILIA
    STEIGER, B
    WHITE, JG
    KRIVIT, W
    JOURNAL-LANCET, 1962, 82 (10): : 421 - &
  • [39] DIURETIC ACTIVITY OF EPSILON-AMINOCAPROIC ACID
    GARRETT, J
    SILVA, RCF
    MENDESCO.MN
    PHARMACOLOGIST, 1968, 1 (01): : 43 - &
  • [40] Rhabdomyolysis induced by epsilon-aminocaproic acid
    Seymour, BD
    Rubinger, M
    ANNALS OF PHARMACOTHERAPY, 1997, 31 (01) : 56 - 58
12345